The Growth of the Biologics Market and Role of Asia Pacific

More Asia Biopharmaceuticals Reports

Research Report on Chinese Bio-pharmaceutical Industry, 2012 by China Research and Intelligence Co., Ltd.
In China, biological products consist of vaccines, blood products, cytokine, diagnostic reagents and other active agents (including toxins, antigens, allergen, and recombinant DNA products, etc.). ...

Biosimilars: China Update by Datamonitor
Biosimilars: China Update provides analysis on the Chinese biogenerics market. It includes an overview of drivers and resistors to biogeneric uptake, market access strategies, key ...

Biosimilars: China Update by Datamonitor
Currently, there is no definition, guidance or pathway for biosimilars in China, with domestically manufactured versions of biologics, known as biogenerics. Due to limited R&D ...

Biosimilars: Japan Update by Datamonitor
Datamonitor’s report Biosimilars: Japan Update provides analysis on the Japanese biosimilars market. It includes an overview of drivers and resistors to biosimilars uptake, market access ...

Biosimilars: Japan Update by Datamonitor
Japan issued its final guidance for biosimilars approval in March 2009, effectively opening up the world’s second largest pharmaceutical market to biosimilar competition. Although this ...

See all reports like this >>

More Asia Reports

D&B Country RiskLine Report: Vietnam by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country RiskLine Report: Uzbekistan by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country RiskLine Report: Turkmenistan by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country RiskLine Report: Turkey by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country RiskLine Report: Thailand by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

See all reports like this >>